Full text is available at the source.
Abstract
Extensive empirical evidence consistently supports the safety of approved genetically modified (GM) crops for human health and environmental protection.
- Regulatory frameworks for GM crops vary significantly across the globe, with the European Union favoring stringent process-based systems while the USA utilizes product-based frameworks.
- Technological advances, such as genome editing with CRISPR-Cas9, offer potential improvements in precision and efficiency but encounter regulatory uncertainties.
- Public acceptance of GM crops shows considerable regional variations influenced by risk perception, trust in authorities, and cultural factors.
- There are notable gaps in long-term ecological monitoring and cumulative assessment of GM crops.
- Regulatory disparities create trade constraints that disproportionately affect developing nations, posing economic implications for global agriculture.
- Current assessments suggest GM crops have matured as a biotechnology with the potential to enhance productivity, stress tolerance, and nutritional quality.
Simplified